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ABSTRACT: A Cytokeratin 8 (K8)/Green Fluorescent Protein (GFP) fusion construct was created to better understand the behavior of K8 within cancer cells. This intermediate filament (IF) protein is a member of the cytoskeletal
gene family, along with actin and tubulin. IFs are normally expressed in a tissue-specific and differentiation-dependent
manner, in which their role is more supportive than essential to the cell. Such roles include rigidity of cellular shape,
protein trafficking, cellular locomotion, and cell-signaling platforms. K8 mutation, over-expression, and aberrant post
translational modifications have been observed in various carcinoma cell lines to be the cause of several phenotypes,
including apoptosis inhibition, drug resistance, transformation, Mallory-Denk body formation, localization at the
plasma membrane, and secretion of the protein.
To study these abnormal phenotypes, the K8 gene was isolated and inserted into the GFP over expression vector.
Transfecting this vector into HeLa cells allowed for the study of K8 within a well-defined cervical cancer cell line. This
study was intended to provide answers to K8’s localization at the plasma membrane in carcinoma cell models while
avoiding criticisms to previous immunohistochemical localization studies. A cellular model of K8 processing that
exhibits established phenotypes found in the literature was thus created and has the potential to address several paramount questions related to K8’s role in supporting the development and progression of cancer. It could also be utilized
as an assay for the discovery of K8 filament formation inhibitors, which may prove useful in combination with current
chemotherapeutics. The model could also be used to provide weight to diagnostics, such as the CAncer REcognition
test, which utilizes antibodies against K8 as biomarkers for malignancy via an Enzyme-Link ImmunoSorbent Assay.
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INTRODUCTION
Early cancer detection and disease monitoring methods
are crucial to patient survival. When a tumor is still in its
tissue of origin, the disease is far more manageable and
treatments produce more optimistic prognoses; for this
reason, it is paramount to identify the presence of cancer
cells as early as possible. Unfortunately, modern medicine
is strongly focused on treatment and less on prevention.
Only when both are utilized in an efficient and timely
manner can future generations hope to see a decline in
the morbidity and mortality caused by this disease.
Most cancers arise through genetic mutations in growth
regulatory circuits resulting in uncontrolled proliferation
or defects in programmed cell death pathways. While
these mutations can be the cause of the disease, they can
also lead to its detection and treatment. Subtle yet
significant surface alterations, or tumor markers, can be
found on carcinoma cells which differentiate them from
the surrounding normal tissue. Having the ability to
differentiate normal cells from those which have
transformed is a rational foundation for the development
of a diagnostic test for the presence of the disease.
One such alteration can be found in cytokeratin 8’s (K8)
aberrant localization in several carcinoma cell lines. K8 is
a cytosolic protein and a member of the Intermediate
Filament (IF) family. IFs, together with actin and tubulin,
define the cytoskeleton of eukaryotic cells, with IFs
representing the largest of the cytoskeletal gene families.
IFs are expressed in a tissue-specific and differentiationdependent manner, and they serve various purposes,
including rigidity of cellular shape, intracellular
organization of proteins, transport, locomotion of the
cell, scaffolding functions, and cell signaling platforms
(Strnad et al. 2008). Since these proteins assist in such a
variety of ways, they frequently interact with numerous
kinases, adaptor, and apoptotic proteins.
Keratin nomenclature breaks down the group into two
sub-types based on their pH: acidic keratins known as
type I and basic keratins known as type II. Type I and
type II keratins bind with each other to create
heteropolymer filaments. Specific keratin pairs are
preferentially expressed in individual cell types (Strnad et
al. 2008); one commonly expressed type I/type II pair of
interest is K8 and K18. This keratin pair is observed in
almost all single-layered epithelia cells (Strnad et al.
2008).

https://stars.library.ucf.edu/urj/vol4/iss2/6

IF proteins’ supportive rather than essential intracellular
roles allow for mutations to go unchecked and lead to
cellular characteristics such as chemotherapeutic
resistance (Lau & Chiu 2007; Wang et al. 2008; Liu et al.
2008), transformation (Raul et al. 2004; Gilbert,
Loranger, Daigle, & Marceau 2001; Gires et al. 2006),
and an aggregation of the K8 into inclusion bodies
known as Mallory-Denk Body formations (Gires et al.
2006; Ku & Omary 2000). So how can we use the
mutation of K8 to our advantage in the detection of
cancer?
Previous studies discovered a high titer of IgM antibodies
within cancer patients which bound specifically to an
epitope found on K8 named LT-11. These studies led to
the initial development of an Enzyme Linked
ImmunoSorbent Assay (ELISA) diagnostic termed the
CAncer REcognition (CARE) test (Thornthwaite et al.
2004). The assay utilizes the Anti-K8 antibodies found
selectively in cancer patient serum as a sensor for tumor
presence; but, in order to present itself to the immune
system, intracellular K8 must somehow be localizing at
the cell surface or releasing itself from the cell due to lysis
or secretion. Investigations exploring how K8 was being
presented to the immune system, and why it was
considered foreign only in the case of tumor cells, needed
to be carried out.
To better understand this phenomenon a model system
was generated to study the localization of K8 within a
cancer cell. Localization studies had been previously
carried out (Gires et al. 2005), but with substantial
criticisms. In said study, “non permeabilized” cells were
subjected to staining using anti LT-11 antibodies and
imaged via fluorescence microscopy. Results showed a
strong signal at the plasma membrane, signifying the
presence of K8 at the cell’s surface. Unfortunately, the
study’s use of potentially membrane destabilizing
immunostaining techniques could have generated false
signals of the protein’s presence at the cell surface. By
utilizing a green fluorescent protein (GFP) tag bound to
K8, our new model avoided the need for immunostaining
and allowed us to image the protein directly. It also
created a platform which could be utilized to explore
new questions regarding the aberrant behavior of K8.
It is of great importance to develop a K8 over-expression
cellular model that exhibits the same phenotypes as the
various carcinomas documented in the literature. Our
study is thus the creation of a model system in which
K8’s biochemical characteristics within cancer can be
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observed. These studies aimed to empower potential
diagnostics utilizing K8 and develop an assay which
could be used for the discovery of novel drug inhibitors
of K8/K18 formation.
METHODS AND MATERIALS
Target Gene Isolation
The K8 gene was generated utilizing a colon cancer
(HCT-116) cell line cDNA library, created in our
laboratory by graduate student Jose Salvatico. First K8-F
(5’- GGT TCT CCG CTC CTT CTA GG -3’) and
K8-R (5’- CTC CTG TTC CCA GTG CTA CC -3’)
primers containing no restriction enzyme (R.E.) sites
were used in a polymerase chain reaction (PCR) to
generate the K8 gene. PCR profile was as follows: 30
cycles (95 °C, 15 sec, 51-61 °C gradient, 30 sec, 68 °C, 1
min 30 sec). All PCR reactions were carried out using
Eppendorf ’s Master Cycler Gradient thermocycler. The
elongation time needed for the K8 gene was calculated
using the following ratio: approximately 1 Kb per 60 sec
(K8 = 1.4 Kb ≈ 1 min 30 sec). Annealing temperatures
ranging from 51 to 63 degrees were used to test for the
primer’s optimum conditions. PCR product yields were
determined by loading samples onto a 1% agrose gel,
separating samples via electrophoresis and staining the
gel with Ethidium bromide (EtBr). The greatest and
purest yield (brightest signal band) was found at 54.3 °C.
The PCR product taken from this tube was purified via
the QIAquick PCR purification kit, provided by
QIAGEN (Valencia, CA).
Next, custom K8 inserts were created for both the
EGFP-C and EGFP-N plasmids from BD Biosciences
(San Jose, CA). The K8-N insert was generated using
CK8R1-NF (5’- A TAT GAA TTC GCC ACC ATG
TCC ATC AGG GTG ACC CAG -3’) and Krt8NBamH1-Rev (5’- T ATT GGA TCC AA CTT GGG
CAG GAC GTC AGA -3’) primers. The K8-C insert
was generated using Krt8C-EcoR1-Rev (5’- T AAT
GAA TTC A ATG TCC ATC AGG GTG ACC
CAG-3’) and ck8BH1-CR (5’- T TAT GGA TCA CTT
GGG CAG GAC GTC AGA AAG TGA -3’). These
primers were placed in separate tubes with the K8
template DNA, and PCR was carried out with the
following profile: (95 °C, 15 sec, 54.3 °C, 30 sec, 68 °C, 1
min 30 sec). PCR product yields were then observed on
a 1% agrose gel. The PCR products were then purified via
QIAquick PCR purification. Both K8-C and K8-N
inserts were then R.E. digested using EcoR1 and BamH1

Published by STARS, 2009

in React 3 buffer provided by Invitrogen (Carlsbad, CA)
at 37 °C for 1 ½ hr.
Digested samples were then purified via Phenol/
Chloroform and Ethanol (P/C/Ethanol) precipitation.
Each DNA sample was adjusted to 110 μl total volume
by adding de-ionized H2O (dH2O). This process was
followed by the addition of 30 μl of Phenol/Chloroform.
The samples were centrifuged at 14,000 rpm for 5 min,
the top 100 μl of solution were transferred to a new tube
and the following were added: 10 μl 3 M NaOAC, 1 μl
glycogen and 300 μl 100% ethanol kept at -20 °C. The
tubes were then incubated at -80 °C for 15 min. DNA
was pelleted by centrifugation at 13,000 rpm for 15 min
at 4 °C and supernatant was removed. The pellet was
then resuspended in 100 μl of 70% ethanol kept at -20
°C and re-pelleted at 14,000 rpm for 5 min at 4 °C.
Supernatant was removed and pellet was allowed to dry
at room temperature. DNA was finally resuspended in
15 μl of dH2O.
Ligation
K8-C and K8-N were inserted into either EGFP-N or
EGFP-C plasmids to create K8/GFP-N and GFP/K8C. First the DNA concentrations of both the plasmids
and inserts were measured at 260 nm by loading 2 µl of
sample with 98 µl of dH2O using TECAN’s GENios 96
well plate reader (Männedorf, Switzerland). Then
EGFP-C was mixed with K8-C and EGFP-N was
mixed with K8-N in the following ratios (Insert to
Plasmid): 6:1 and 12:1. Ligation was carried out at room
temp (approximately 22.5 °C) for 1 hour. Ligated
products were then purified via P/C/Ethanol
Precipitation and re-suspended in 20 μl of dH2O
(plasmids were maintained at a high concentration to
increase transformation efficacy).
Transformation
K8/GFP-N and GFP/K8-C were transformed into XLGold Escherichia coli Ultra Competent cells provided by
Stratagene (La Jolla, CA) via heat shock. XL-Gold E.coli
cells were first thawed on ice and treated with
β-mercaptoethanol. Both the 6:1 and 12:1 ligation
products were mixed together, placed with cells and
allowed to set for 30 min on ice. Cells were then placed
in a dry bath at 42 °C for 30 sec then allowed to grow in
Luria-Bertani (LB) media for 45 min in an incubator
shaker at 37 °C. Cells were pelleted, plated on Kanamycin
(Kan) selective plates and incubated over-night. Colonies
were selected and placed in 3 mL of LB (Kan) media for
15 hrs in a shaker incubator at 37 °C.
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Screening of Colonies
Plasmids from cultured cells were harvested via QIAprep
Spin Mini Prep Kit, provided by QIAGEN. The isolated
plasmids were digested with EcoR1 and BamH1 at
37 °C and analyzed on a 1% agrose gel to confirm
insertions. Positive clones were found for GFP/K8-C,
while all of the K8/GFP-N plasmids were negative for
the K8 insert. The process of ligation and the
aforementioned procedures were repeated for the K8/
GFP-N plasmid using Max Efficiency® DH5-α-T1
competent E. coli cells (Invitrogen).
Plasmid Sequencing
Positive clones were chosen and grown in 3 mL of LB
(Kan) media. These cultures were harvested and plasmid
DNA concentrations were then measured at 260 nm
with a 280 nm purity reference. GFP/K8-C and K8/
GFP-N were sent to GENEWIZ (South Plainfield, NJ)
for sequencing. Results came back 99% homologous to
K8’s sequence found in the National Center for
Biotechnology Information database with one silent
mutation.
Verification of Expression
Both GFP/K8-C and K8/GFP-N plasmids were
transfected into HeLa (Cervical) and MDA-MB-231
(Breast Cancer) cell lines for the purpose of Western blot
confirmation of K8/GFP fusion protein expression.
First, both cell lines were grown to 95% confluency on a
6 well plate. Next, 1 μg and 2 μg of each plasmid were
added to separate tubes containing 250 μl of OPTIMEMI media (1 μg of a blank DNA was added to the 1
μg plasmid tubes to keep DNA concentrations constant).
A 8 μl volume of Lipofectamine™ 2000 (Invitrogen) was
mixed with 250 μl of OPTI-MEMI media for each
transfection well, then added to the DNA/OPTIMEMI suspensions and incubated at room temperature
for 20 min. Growth media was removed from each well
and 500 μl of the Lipofectamine/plasmid mixture was
added. HeLa cells were then given 1 ml of serum free
RPMI, while MDA-MB-231 cells were given 10% FBS
DMEM media. Plates were gently rocked to spread
plasmid evenly and placed in the culture incubator for 24
hrs; 1 ml of 20% RPMI was given to the HeLa cell
cultures after 5 hrs.
Media was removed from all transfection wells, then cells
were trypsinized and pelleted in a microcentrifuge at
room temperature. Cells were then washed with 1ml of
phosphate buffered saline (PBS), and re-suspended in
50 μl of 1x radio-immunoprecipitation assay buffer
https://stars.library.ucf.edu/urj/vol4/iss2/6

containing ethylenediaminetetraacetate(EDTA)-free
protease inhibitor cocktail (Roche Diagnostics). Tubes
were placed on ice for 30 min then centrifuged at 14,000
rpm for 10 min at 4°C. The supernatant (cytosolic
fraction) was transferred to a new tube and the protein
concentrations were measured via Bradford assay.
Protein samples were suspended in 5x SDS loading dye
containing: 2.0 ml 1 M Tris-HCl pH 6.8, 0.8 g SDS, 4.0
ml 100% glycerol, 0.4 ml 14.7 M β-mercaptoethanol, 1.0
ml 0.5 M EDTA and 8 mg bromophenol Blue. Samples
were heated at 95 °C for 5 min and approximately 10 μg
were loaded onto a .75 mm 10% polyacrylamide gel.
Electrophoresis was carried out at 80 volts for 60 min
then 150 volts for 25 min. Proteins were then transferred
to a nitrocellulose membrane at 100 volts for 90 min. The
membrane was then probed for the GFP and Actin (to
act as a loading control) with the following antibodies
(and their concentrations): Primary antibodies- (1:1,000
mouse α-GFP) and (1:10,000 Rabbit α-actin), Secondary
antibodies- (1:1,000 Goat α-rabbit IgG, Horseradish
Peroxidase(HRP)-conjugated) and (1:1,000 Goat
α-mouse IgG, HRP-conjugated). Antibodies came from
the following sources: Mouse α-GFP and Goat α-mouse
IgG (Santa Cruz Biotechnology), Rabbit α-actin
(Sigma) and Goat α-rabbit IgG, HRP-conjugated
(Pierce). Remaining samples were stored at -80 °C.
Twelve days later western blot procedures were repeated,
utilizing those samples taken from cells transfected with
2 μg of plasmid.
Slide Preparations
After Western blot analysis showed the presence of the
fusion protein, confocal imaging of K8/GFP was carried
out. Plasmids were transfected into the HeLa cell line,
which was grown on glass cover slips. The transfected
cells were prepared and sealed onto microscope slides
and then imaged by confocal microscopy.
HeLa cell cultures were grown to 40% confluency on
glass coverslips. Following this, 1 μg of GFP/K8-C or
K8/GFP-N plasmids were transfected into separate
HeLa cultures (see Verification of Expression Product for
procedure). The cover slips were transferred to a new 12
well plate, 2 ml of 2% Paraformaldehyde were added to
each well and allowed to incubate at room temperature
for 15 min. Wells were washed by decanting the
supernatant, adding 3 ml of PBS, incubating for 2 min
and removing the PBS; this process was done twice.
To-Pro 3 Iodide (1:5000 dilution) in 1 ml PBS was
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added to each well and incubated in darkness for 30 min
to counter-stain DNA. The samples were kept in darkness
for the rest of the preparations. Wells were washed and
cover slips were mounted onto microscope slides using
10 μl of Vectashield™ mounting solution minus DAPI
(Plasmid). The cover slips were sealed using clear nail
polish, and dried for 10 min. Slides were then stored at
-20 °C until imaged. Imaging was carried out using the
ZEISS Axiovert 100M confocal microscope and its
associated software.
To evaluate K8/GFP localization at the plasma
membrane, Z-stacking was performed. This technique
utilizes the confocal microscope’s ability to block out of
focus light from the detector, therefore accurately
depicting a single focal plane. Several focal planes, from
the bottom of the cell to the top, are then captured and
analyzed. These planes can then be processed and placed
on top of each other, forming a three-dimensional image
which provides better cellular structure detail.
RESULTS AND DISCUSSION
The K8 gene was cloned from a HCT-116 cell line
cDNA library using PCR. This was carried out at varying
annealing temperatures to find optimal conditions (high
product purity and quantity). Figure 1 shows an optimal
product at 54.3 °C annealing temperature. This product
was then inserted into both GFP-C and GFP-N vectors,
and sent in for sequencing.
FIGURE 1: PCR OPTIMIZATION

PCR products created from addition of K8-F and K8-R primers with
HCT-116 cDNA library, carried out at annealing temperatures from
51 to 63°C. Samples were loaded onto a 1% argose gel and run at
75volts for 60min. K8 sequence is 1.4Kb in length.

Sequencing results confirmed that both vectors contain
copies of the K8 gene and had one silent mutation at
nucleotide 680, making them 99% homologous with the
sequence found in the NCBI database (Figure 2). Once
these constructs were transfected into the cancer cell
lines, HeLa and MDA-MB-231, the cytosolic protein
fractions were analyzed for the presence of the desired
fusion product.
Published by STARS, 2009

FIGURE 2: SEQUENCING RESULTS FOR THE
GENERATED K8 INSERT VERSUS THE K8 GENE
FOUND IN THE NCBI DATABASE

One silent mutation, illustrated by above codon translation, was found
in both K8 inserts (K8-C and K8-N) making them 99% homologous
with documented K8 sequence.

Western blot analysis showed a distinct difference in
the post translational modification of K8/GFP-N and
GFP/K8-C in the MDA-MB-231 cell line (Figure 3).
The results show that these cells may be able to process
K8/GFP-N more efficiently than GFP/K8-C, since K8/
GFP-N samples showed little to no signal around the
80.5 kDa region. The K8/GFP was undoubtedly expressed in these cells since the fusion construct generates
a single polypeptide and immunoreactivity was observed
at approximately 27 kDa, the weight of GFP. Thus, the
K8/GFP protein was expressed, but the K8 portion was
preferentially lost due to degradation or secretion.
The results also show a difference in the post translational modification of the fusion protein in MDA-MB-231
cells compared to the HeLa. MDA-MB-231 cells may
be able to proteolytically process K8 more efficiently
than the HeLa cells. If HeLa had an intrinsically higher
level of K18 expression, for example, this would facilitate the protection of the K8/GFP protein by promoting
filament formation when the K8/GFP and K18 concentrations were approximately equal. It is well established
in the literature that the formation of K8/K18 filaments
helps to protect the two proteins from degradation (Gilbert, Loranger, Daigle, & Marceau 2001).
Further observations showed the presence of multiple
K8/GFP fragments exclusively within HeLa cells
transfected with the GFP/K8-C plasmid; such distinct
fractions were not observed in the same concentration of
protein sample taken from the K8/GFP-N transfected
cells (Figure 4).
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FIGURE 3: VERIFICATION OF GFP/K8-C AND K8/GFP- N EXPRESSION IN MDA-MB-231 AND HELIA WESTERN
BLOT UTILIZING α-GFP.

Western blots were probed with both α-GFP and α-Actin.The GFP-K8 fusion product has an expected molecular weight of: ~53.5kDa (K8) +
~27kDa (GFP) - ~80.5kDa. A GFP product which has been cleaved off of K8 at ~27kDa was observed in all the transfected cells, while no Actin
bands were present at ~39kDa. Cell extracts from those transfected with the GFP plasmid were used as a GFP molecular weight marker. (a) The
MDA-MB-231 cell line showed a decreased presence of GFP/K8-C compared to HeLa, potentially due to more efficient degradation/secretion of
the K8 portion of the construct. (b) The HeLa cell line showed relatively high levels of expression for both GFP/K8-C and K8/GFP-N. A distinct
GFP/K8-C fragmentation was also observed in lanes (8-9), while K8/GFP-N lanes (11-12) displayed little to no fragmentation bands.

FIGURE 4: SECONDARY VERIFICATION OF GFP/K8-C AND K8/GFP-N EXPRESSION AND FRAGMENTATION

Western blot procedures were repeated after samples were frozen for two weeks to confirm previous expression results and GFP/K8-C exclusive
fragmentation. All results, except for the presence of an Actin band at ~39kDa, were concurrent with the previous experiment. The GFP fusion
product has a calculated molecular weight of ~80.5kDa. (a) The MDA-MB-231 cell line showed decreased GFP/K8-C presence in lane (4), no
K8/GFP-N in lane (2) and the presence of an Actin band. (b) The HeLa samples continued to show both the GFP/K8-C and K8/GFP-N products,
while fragmentation continued to remain exclusive to GFP/K8-C in lane (6). A distinct Actin band was not observable in the HeLa extracts, until
an extended exposure of the blot was taken.

https://stars.library.ucf.edu/urj/vol4/iss2/6
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Previous literature supports the concept of extensive K8
post translational modifications, proteolytic cleavage
(Ku, Zhou, Toivola & Omary 1999) and the secretion of
full length K8 as well as its fragments in some forms of
lung cancer (Yoko et al. 2002). Combining this information with the documented localization of K8’s C-terminal epitope LT-11 at the cell surface (Gires et al. 2005)
allowed for a model to be generated to help address the
difference in the observed fragmentation (Figure 5). In
this model, GFP’s position in relation to K8 is important
in understanding the difference in the detectable bands
prouced. From the literature (Gires et al. 2005; Yoko

et al. 2002) one could hypothesize that K8 is degraded
and those protein fragments closest to the LT-11 epitope end up on the outside of the cell membrane, whether it be secreted or inserted. GFP/K8-C encodes for a
protein with GFP at the N-terminus of K8 (furthest
away from the LT-11 C-terminus epitope), producing
fragments which remain in the cytosol that are detectable when probing cytosolic fractions with α-GFP. In
the case of K8/GFP-N, GFP is encoded directly after
the LT-11 epitope which will facilitate its export out
of the cytosol, leaving only full length K8 detectable
within the cell.

FIGURE 5: MODEL PREDICTING CAUSES OF FGP/K8-C'S FRAGMENTATION SIGNAL

The above model shows predicted destinations of cleaved GFP/K8 fragments and detectability of the fragments using α-GFP. Those fragments that
remain within the cytosol and have intact GFP should theoretically be present on a western blot of a cytosolic fraction (Figures 4 and 5).

Published by STARS, 2009
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Confocal imaging was carried out utilizing the HeLa
cell line due to its relatively increased expression levels compared to the MDA-MB-231 line. These images
showed distinct IF formations in HeLa cells transfected with either GFP/K8-C or K8/GFP-N, while those
transfected with the original GFP plasmid showed a
ubiquitous signal throughout the cell without any welldefined pattern (Figure 6). The ability of the fusion
construct to form IF networks demonstrates that the
construct is a fully functional K8 protein. Additionally,
these images showed an IF structure formation within
the cells transfected with the fusion protein construct,
while lacking the distinct signal at the plasma

membrane one would expect from the Gires study (Gires
et al. 2005). In Gires’s study, anti-K8 antibodies were
used to probe for the protein’s presence at the plasma
membrane of non-permeabilized carcinoma cells. Images produced in that study showed K8 localization universally across the entire membrane which created a shell
outline of the cell. The lack of a well-defined signal at
the plasma membrane by the K8/GFP protein, while exhibiting a distinct cytoskeleton structure, suggested that
the extracellular projection of K8 reported by Gires et.
al. is an artifact of their immunohistochemical procedure
(Gires et al. 2005). Since K8 is bound to GFP in our
system, it can be imaged directly, thereby overcoming the
limitations of the previous study.

FIGURE 6: K8/GFP DISPLAYS INTERMEDIATE FILAMENT FORMATIONS

HeLa cells were transfected with the above mentioned plasmids and their DNA was stained using To-Pro 3 lodide. Those transfected with only
GFP showed localization throughout the cell and no structural formation, while cells transfected with either GFP/K8-C K8/GFP-N showed
cytosolic localization and intermediate filament formation.

https://stars.library.ucf.edu/urj/vol4/iss2/6
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Preliminary immunoprecipitation (IP) studies of media taken from HeLa cells transfected with both GFP/
K8-C and K8/GFP-N utilizing α-GFP antibodies were
performed over a 72 hr period, collecting media and
harvesting cells every 24 hrs (data not shown). Samples
were run through Western blot procedures after the IP,
probing with an α-GFP antibody. A protein band immunoreactive with α-GFP antibody was observed at the
anticipated 80.5 kDa mobility of K8/GFP, but no noticeable lower molecular mass fragments were observed.
It is possible secreted K8/GFP fragment bands may have
been obscured by the robust signal produced from the
heavy chain of α-GFP IgG utilized to pull the fusion
protein out of the media.
These results provide a strong indication that the protein produced by these plasmids was in fact K8 fused to
GFP in a functional conformation. Within the transfected HeLa cells, a well-defined IF network incorporated
products from both of the GFP/K8-C and K8/GFP-N
plasmids. Also, phenotypes such as the secretion of the
fusion product into the media and the aggregation of
the product into K8 containing inclusion bodies (data
not shown) were observed. These findings would lead us
to conclude that the developed model system correlates
well with what would be expected from the current K8
literature, and that K8 may not ubiquitously localize at
the plasma membrane as once hypothesized (Gires et al.
2005).
FUTURE DIRECTIONS FOR THE PROJECT
Future experiments, such as secretion and localization
studies, will help to provide answers to K8’s role in
precancerous cell transformation. In order to evaluate
the model presented in Figure 5, secretory studies
could be performed on K8/GFP-N expressing HeLa
cells. First, samples of media taken from these cell
cultures would be subjected to immunoprecipitation
utilizing anti-GFP antibodies. Western blot analysis
would then help to show if partially degraded K8
bound to GFP was being secreted or released
preferentially from the K8/GFP-N expressing cells.
Other secretory studies utilizing GFP and Red
Fluorescent Protein (RFP) molecular tags could be
carried out by transfecting a culture of cells with K8/
GFP and mixing them with cells transfected with K8/
RFP. If K8/RFP protein is observed on a cell expressing
K8/GFP, or K8/GFP protein on a K8/RFP expressing
cell, the co-localization of the two fluorophores will
Published by STARS, 2009

generate a yellow signal. If such a signal were observed,
one could then conclude that cancer cells have the
ability to secrete and attach K8 onto neighboring cells
(Figure 7A). Similar evaluations of K8’s potential to
stick to the outer membrane surface could be studied
by purifying the K8/GFP product and adding it at
varying concentrations to non-transfected cell
cultures. Those cultures could then be imaged under a
confocal microscope to check for the presence of the
fusion protein on the outside of non-permeabilized
cells.
Localization studies could also be carried out utilizing
K8/GFP transfected cells in direct comparison to
Actin/GFP transfected cells, since actin is a known
cytosolic protein. Non-permeablized cells could then
be probed with a primary α-GFP and a red fluorescent
secondary antibody to better evaluate if the observed
localization of K8 is an artifact or not (Figure 7B).
These experiments could exploit the advantages of
the immunofluorescences approach, while actively
addressing criticisms to a “leaky membrane.”
Finally, the current model could be utilized as an assay
for the discovery of K8 filament formation inhibitors.
Since K8’s role is considered relatively more supportive
than essential and the deconstruction of its filaments
have been found to attenuate drug resistance (Lau &
Chiu 2007; Wang et al. 2008; Liu et al. 2008), alleviate
aggressive metastatic phenotypes (Raul et al., 2004;
Gilbert, Loranger, Daigle, & Marceau 2001) and in
some cases, promote proapoptotic receptors at the cell
surface (Gilbert, Loranger, Daigle, & Marceau 2001),
it may be considered as a potential target for cancer
therapeutics. By adding various potential inhibitors
and monitoring K8/K18 filament formation under a
confocal microscope, the model has the potential to
discover new drugs which may be useful alone or in
combination with current chemotherapeutics against
various forms of carcinoma.
By utilizing this model system and beginning
preclinical trials of the CARE test (Thornthwaite et
al. 2004), K8’s true potential as a tumor marker can be
elucidated. One day, such a diagnostic could be used to
screen large numbers of patients for a variety of
cancers during routine blood work in order to catch
the disease when it is at a more manageable stage.
Early cancer detection will enable old and new
treatments alike to become far more effective, and
allow such procedures to produce far more optimistic
prognoses.
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FIGURE 7: FUTURE SECRETION AND LOCALIZATION STUDIES

A K8/GFP (green) and K8/RFP (red) secretion onto neighboring cells and resulting potential signal (yellow).
B Immuno-fluorescencent determination of K8's localization at the plasma membrane.
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